RELX is a global provider of information-based analytics and decision tools serving professional and business customers across multiple sectors including Risk (LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier), Legal (LexisNexis Legal & Professionals), and Exhibitions (Reed Exhibitions). Their purpose is to benefit society by developing products that advance scientific knowledge, improve healthcare outcomes, support justice and the rule of law, prevent fraud, and facilitate market transactions. RELX’s lobbying efforts at the EU level focus on influencing policies and regulations that impact data use, artificial intelligence, copyright, research, cybersecurity, financial services, and anti-money laundering, among others.
RELX has been registered in the EU Transparency Register since 15 May 2013. It actively targets key EU legislative files such as the Artificial Intelligence Act, the Digital Single Market Directive on Copyright, the European Research Area, the Data Act, AI Liability Directive, GDPR, AML/CFT packages, sanctions policy, digital operational resilience (DORA), digital finance, eIDAS 2, and the European Media Freedom Act.
The company maintains offices in London (headquarters) and Brussels (EU office), employing approximately 5 lobbyists with a full-time equivalent of about 1.75. Among these, 3 lobbyists hold European Parliament accreditation. RELX engages regularly with EU institutions, having held around 30 high-level Commission meetings in recent years.
Financially, RELX’s declared lobbying expenditure in 2023 was between €500,000 and €599,999. Historical data shows spending around €450,000 in 2017 and consistent engagement over the years. Their lobbying activities are aligned with their corporate mission to support data-driven decision-making and regulatory frameworks that foster innovation and fair market practices in their sectors.